MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Mitochondrial dysfunction"

  • 2018 International Congress

    PLG restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models

    J. Liu, H. Yang (Beijing, China)

    Objective: Parkinson disease (PD) is the second most common neurodegenerative disorder after Alzheimer disease and there are few treatments currently available. The present study investigated…
  • 2018 International Congress

    Mitochondrial morphometrics in idiopathic Parkinson‘s disease fibroblasts

    P. Antony, O. Boyd, K. Mommaerts, K. Sokolowska, M. Ostaszewski, A. Baumuratov, L. Longhino, F. Poulain, R. Krueger, R. Balling, N. Diederich (Belvaux, Luxembourg)

    Objective: To identify mitochondrial morphometric phenotypes in fibroblasts derived from patients with idiopathic Parkinson’s disease (IPD). Background: Mitochondrial dysfunction (MD) has been proposed as cellular…
  • 2018 International Congress

    Genetic defects causing complex movement disorders and basal ganglia degeneration in childhood

    H. Baide-Mairena, L. Martí-Sánchez, J. Muchart, M. Rebollo, E. Turón, JC. Cabrera López, Y. Tong-Hong, M. Madruga-Garrido, O. Alonso-Luengo, P. Quijada-Fraile, M.T. García-Silva, A. Cerisola, R. Velazquez-Fragua, E. Schuler, E. López-Laso, L. Gutiérrez-Solana, C. Cáceres-Marzal, I. Marti, O. García-Campos, M. Tomas-Vila, A. Macaya, H. Ben-Pazi, G.I. Rice, Y. Crow, R. Pons, J.D. Ortigoza-Escobar, B. Pérez Dueñas (Barcelona, Spain)

    Objective: To characterize genotype–phenotype correlations in basal ganglia degeneration (BGD) in childhood. Background: BGD in childhood causes movement disorders, neurodevelopmental dysfunction and long-lasting severe disability.…
  • 2018 International Congress

    Movement disorders in mitochondrial disease: Radio clinical correlation in pediatric patients

    R. Zouari, M. Naifar, F. Kamoun, S. Ben Nsir, R. Ben Jemaa, W. Bouchaala, F. Ayadi, C. Triki (Sfax, Tunisia)

    Objective: Investigate the clinical features of movement disorders (MD), as well as brain imaging findings, in order to identify a radio-clinical correlation in mitochondrial diseases…
  • 2018 International Congress

    Juvenile parkinsonism associated with a novel HSD17B10 mutation in a patient with HSD10 disease

    M. Rosário, O. Moldovan, S. Reimão, I. Chendo, J. Crawford, M. Rosa, L. Guedes (Lisbon, Portugal)

    Objective: We describe the case of a female patient with HSD10 disease associated with parkinsonism, with a novel mutation in the HSD17B10 gene. Background: HSD10…
  • 2018 International Congress

    Mitochondrial phenotype related to the A30P alpha-synuclein mutation as a patient-derived cellular model of Parkinson’s disease

    B. Santos, P. Barbuti, P. Antony, J. Arias, A. Hummel, J. Schwamborn, R. Krüger (Belval, Luxembourg)

    Objective: Our study aims to perform detailed phenotyping of the A30P alpha-synuclein familial case of PD, allowing to identify underlying mechanisms of the disease that…
  • 2018 International Congress

    Abrogation of Rotenone Induced Behavior, Biochemical and Mitochondrial Deficits in Mice by Curcumin and Ginkgo Biloba: New Combinational Therapy Approach for Parkinson’s Disease

    D. Khatri, M. Panchwadkar, P. Rane, V. Undale (Pune, India)

    Objective: This study was designed with the objective to find out the possible synergistic effect of Curcumin (Cur) and Methanolic extract of Ginkgo biloba (EGB)…
  • 2018 International Congress

    Challenging mitochondria in idiopathic Parkinson‘s disease fibroblasts

    P. Antony, O. Boyd, K. Mommaerts, K. Sokolowska, M. Ostaszewski, A. Baumuratov, L. Longhino, F. Poulain, R. Krueger, R. Balling, N. Diederich (Belvaux, Luxembourg)

    Objective: Evaluate mitochondrial integrity in cultivated fibroblasts of patients with idiopathic Parkinson’s disease (IPD) and healthy controls (HC). Background: Mitochondrial dysfunction (MD) is considered an…
  • 2017 International Congress

    Metabolomic biomarkers strongly differentiate PD from healthy controls (HCs) in BioFIND study* specimens

    P. LeWitt, J. Li, M. Lu, K.-H. Wu, Y. Zhou, I. Datta, L. Guo, B. Investigators (West Bloomfield, MI, USA)

    Objective: To determine if metabolomic analysis - untargeted profiling of small-molecule (<1.5 kDalton) biochemical constituents - can yield useful diagnostic biomarkers of PD using CSF…
  • 2017 International Congress

    Neuroprotective effect of α-Mangostin in restoration mitochondrial function in MPTP-Induced Parkinson’s disease in mice

    A. Prakash, A.B. Majeed, K. Ramasamy, M. Hasan (Baltimore, MD, USA)

    Objective: The aim of the present study was to explore the protective effect of alpha-mangostin against mitochondrial oxidative stress in MPTP treated mice. Background: It…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley